Karin Regnstrom

Title: **Karin Regnstrom: Innovator in Monoclonal Antibody Development**

Introduction

Karin Regnstrom is a notable inventor based in San Francisco, California. With her innovative work in the field of biotechnology, she has made significant contributions to the development of humanized monoclonal antibodies. Her expertise lies in creating optimized antibodies that can effectively target specific proteins, paving the way for advancements in medical treatments.

Latest Patents

Karin holds one patent titled "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." This patent describes optimized humanized antibodies that selectively bind to and inhibit activated protein C, while not affecting unactivated protein C. The antibodies are designed to interact with specific epitopes outside the catalytic triad of the active site of human activated protein C. The methods of treatment utilizing these antibodies are fundamental to potential therapeutic applications in medicine.

Career Highlights

Karin Regnstrom works at the Oklahoma Medical Research Foundation, where she continues to push the boundaries of scientific research. Her dedication to her work has led her to pioneer solutions aimed at complex medical issues involving activated protein C. Her commitment to innovation is reflected not only in her patent but also in her continuous research efforts within the organization.

Collaborations

Throughout her career, Karin has collaborated with fellow researchers such as Xiao-Yan Zhao and Andreas Wilmen. These partnerships enhance her work and contribute to the broader scientific community, allowing for a more comprehensive approach to the challenges faced in biomedicine.

Conclusion

Karin Regnstrom stands out as an inspiring figure in the field of biotechnology. Her groundbreaking patent and collaborative spirit highlight her status as an innovative inventor dedicated to improving medical treatments. As she continues her work at the Oklahoma Medical Research Foundation, the impact of her discoveries will likely resonate in the industry for years to come.